Remarks on signing the project BioShield Act of 2004

Weekly Compilation of Presidential Documents, July 26, 2004

July 21, 2004

The President. Thank you all. Mr. Speaker. Please be seated. Thanks. Good morning, and welcome to the Rose Garden.

On September the 11th, 2001, America saw the destruction and grief terrorists could inflict with commercial airlines turned into weapons of mass murder. Those attacks revealed the depth of our enemies' determination but not the extent of their ambitions. We know that the terrorists seek an even deadlier technology. And if they acquire chemical, biological, or nuclear weapons, we have no doubt they will use them to cause even greater harm.

The bill I am about to sign is an important element in our response to that threat. By authorizing unprecedented funding and providing new capabilities, Project Bio-Shield will help America purchase, develop, and deploy cutting-edge defenses against catastrophic attack.

This legislation represents the collective foresight and considered judgment of United States Senators and Members of the House of Representatives from both political parties, many of whom experienced bioterror firsthand when anthrax and ricin were found on Capitol Hill. It reflects 18 months of hard work and cooperation by many dedicated public servants in Congress and in the White House. It sends a message about our direction in the war on terror: We refuse to remain idle while modern technology might be turned against us; we will rally the great promise of American science and innovation to confront the greatest danger of our time.

I want to thank the Vice President for his hard work. He was the point man in the White House on this piece of legislation and did an excellent job. I appreciate Secretaries Tommy Thompson and Tom Ridge for their leadership on this important piece of legislation as well.

I appreciate the Speaker and Leader Frist for making this bill a priority. I want to thank Senator Gregg and Senator Kennedy and Senator Cochran for working on this bill. I appreciate the efforts. I appreciate Congressmen Barton, Billy Tauzin, Chris Cox, and Henry Waxman as well for their hard work.

I appreciate the members of my administration who are here. Thanks for coming. These will be the implementers of this important piece of legislation.

Project BioShield will transform our ability to defend the Nation in three essential ways. First, Project BioShield authorizes $5.6 billion over 10 years for the Government to purchase and stockpile vaccines and drugs to fight anthrax, smallpox, and other potential agents of bioterror. The Department of Health and Human Services has already taken steps to purchase 75 million doses of an improved anthrax vaccine for the Strategic National Stockpile. Under Project BioShield, HHS is moving forward with plans to acquire a safer, second-generation smallpox vaccine, an antidote to botulinum toxin, and better treatments for exposure to chemical and radiological weapons.

Private industry plays a vital role in our biodefense efforts by taking risks to bring new treatments to the market, and we appreciate those efforts.

By acting as a willing buyer for the best new medical technologies, the Government ensures that our drug stockpile remains safe, effective, and advanced. The Federal Government and our medical professionals are working together to meet the threat of bioterrorism; we're making the American people more secure in doing so.

Second, Project BioShield gives the Government new authority to expedite research and development on the most promising and time-sensitive medicines to defend against bioterror. We will waste no time putting those new powers to use. Today Secretary Thompson will direct the NIH to launch two initiatives, one to speed the development of new treatments for victims of a biological attack and another to expedite development of treatments for victims of a radiological or nuclear attack. Under the old rules, grants of this kind of research often took 18 to 24 months to process. Under Project BioShield, HHS expects the process to be completed in about 6 months. Our goal is to translate today's promising medical research into drugs and vaccines to combat a biological attack in the future, and now we will not let bureaucratic obstacles stand in the way.

Third, Project BioShield will change the way the Government authorizes and deploys medical defenses in a crisis, When I sign this bill, the Food and Drug Administration will be able to permit rapid distribution of promising new drugs and antidotes in the most urgent circumstances. This will allow patients to quickly receive the best treatments in an emergency. Secretary Thompson has directed the FDA to prepare guidelines and procedures for implementing this new authority. By acting today, we are making sure we have the best medicine possible to help the victims of a biological attack.

Project BioShield is part of a broader strategy to defend America against the threat of weapons of mass destruction, Since September the 11th, we've increased funding for the Strategic National Stockpile by a factor of 5, increased funding for biodefense research at NIH by a factor of 30, secured enough smallpox vaccine for every American, worked with cities on plans to deliver antibiotics and chemical antidotes in an emergency, improved the safety of our food supply, and deployed advanced environmental detectors under the BioWatch Program to provide the earliest possible warning of a biological attack.